Amanta Healthcare Ltd
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products.[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Capacity Utilization - LVP (excl. SteriPort) % ・Standalone data |
|
||||
| Capacity Utilization - SteriPort % ・Standalone data |
|||||
| Installed Capacity - SteriPort (LVP) Crore bottles per year ・Standalone data |
|||||
| Installed Capacity - SVP Crore bottles per year ・Standalone data |
|||||
| Active Export Countries count ・Standalone data |
|||||
| Product Portfolio count ・Standalone data |
|||||
| International Product Registration Jurisdictions count ・Standalone data |
|||||
| Number of Distributors & Stockists count ・Standalone data |
|||||
Extracted by Screener AI
Documents
Announcements
-
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
- Newspaper advertisement issued for special window on transfer and dematerialisation of physical shares.
-
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Amanta Healthcare Limited Announces Commissioning Of New Steriport Line
- Amanta Healthcare commissioned new SteriPort line at Kheda on September 2, 2026, boosting production and margins.
-
Intimation - Regulation 36(1)(B) Of The SEBI Listing Regulations
- 31st AGM on 16 September 2026; annual report web-link shared and KYC reminder issued.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Advertisement for dispatch of Annual Report of the 31st Annual General Meeting and e-voting information
-
Annual Report For Financial Year 2025-26
- Annual Report 2025-26 and 31st AGM notice; meeting on September 16, 2026 via VC/OAVM.
Concalls
-
Aug 2026Transcript PPT REC
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT
Business Profile:[1][2]
Amanta Healthcare is a niche pharmaceutical company specializing in sterile liquid parenteral (injections and infusions) using ABFS and ISBM technologies. It operates across six therapeutic segments: fluid therapy, diluents and injectables, ophthalmic, respiratory solutions, irrigation, and other formulations.
As an integrated LVP and SVP manufacturer,
its products support critical care in oncology, pediatrics, ICU, and anesthesia. Under its “SteriPort” brand for two-port IV systems, management estimates a 50–60% domestic market share in PP IV bottles.